COMMUNIQUÉ DE PRESSE publié le 03/06/2025 à 12:10, il y a 9 mois 19 jours Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth Lobe Sciences Ltd. appoints Mr. Yong Yao as CFO & EVP, leveraging his 25 years of finance & biotech experience to drive financial strategy & growth. Strategic shift to full-time financial leadership Chief Financial Officer Executive Vice President Finance Strategy Lobe Sciences Yong Yao
BRÈVE publiée le 14/04/2025 à 13:05, il y a 11 mois 8 jours Lobe Sciences lance un placement privé pour le développement de médicaments Placement Privé Essais Cliniques Sciences Du Lobe Cynaptec Pharmaceuticals Psilocine Conjuguée
BRÈVE publiée le 14/04/2025 à 13:05, il y a 11 mois 8 jours Lobe Sciences Initiates Private Placement for Drug Development Private Placement Clinical Trials Lobe Sciences Conjugated Psilocin Cynaptec Pharmaceuticals
COMMUNIQUÉ DE PRESSE publié le 14/04/2025 à 13:00, il y a 11 mois 8 jours Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM) Lobe Sciences announces US$6M private placement for Cynaptec to fund Conjugated Psilocin development. Option for additional US$20M included. Company focuses on lipid tech for orphan diseases Private Placement Lobe Sciences Lipid Technology Conjugated Psilocin Cynaptec
BRÈVE publiée le 05/04/2025 à 05:55, il y a 11 mois 17 jours Lobe Sciences Provides Corporate Update on Recent Transactions Clinical Trials Convertible Notes FDA Feedback Lobe Sciences Psilocin Mucate
BRÈVE publiée le 05/04/2025 à 05:55, il y a 11 mois 17 jours Lobe Sciences fournit une mise à jour de l'entreprise sur les transactions récentes Essais Cliniques Billets Convertibles Commentaires De La FDA Sciences Du Lobe Mucate De Psilocine
COMMUNIQUÉ DE PRESSE publié le 05/04/2025 à 05:50, il y a 11 mois 17 jours Lobe Sciences Provides Corporate Update Lobe Sciences provides corporate update on recent transactions and business progress including patents and clinical study results. Focus on lipid technology solutions for medical needs Corporate Update Recent Transactions Lobe Sciences Lipid Technology Medical Needs
Publié le 20/03/2026 à 19:00, il y a 1 jour 20 heures AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Publié le 20/03/2026 à 19:00, il y a 1 jour 20 heures AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Publié le 20/03/2026 à 18:15, il y a 1 jour 21 heures Publication of AXA’s 2025 Universal Registration Document
Publié le 20/03/2026 à 18:15, il y a 1 jour 21 heures Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Publié le 20/03/2026 à 13:30, il y a 2 jours 1 heure Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Publié le 20/03/2026 à 12:30, il y a 2 jours 2 heures CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Publié le 22/03/2026 à 12:23, il y a 2 heures 57 minutes Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Publié le 20/03/2026 à 22:45, il y a 1 jour 16 heures Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Publié le 20/03/2026 à 21:05, il y a 1 jour 18 heures Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Publié le 20/03/2026 à 21:05, il y a 1 jour 18 heures Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Publié le 20/03/2026 à 21:00, il y a 1 jour 18 heures BRP Unveils the Winners of its 6th International Design Challenge